CRSP announcements Crispr Therapeutics Ag announcements and dividends declared USA
Crispr Therapeutics Ag Complete list of announcements declared & dividend announcements by Crispr Therapeutics Ag CRSP
Crispr Therapeutics Ag CRSP listed on USA and deals in Health Care Biotechnology Biological Products No Diagnostic SubstancesAnnouncements and dividends declared by Crispr Therapeutics Ag CRSP
CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms
3 Biotech Stocks That Could Benefit from the Patent CliffCRISPR Therapeutics (NASDAQ:CRSP) Chief Executive Officer Sam Kulkarni said the company is entering a “second phase” as it moves beyond the initial launch of CASGEVY and prepares for data
Announcement as on 16 May 2026
CRISPR Therapeutics Announces Pricing Of 0 Mln Of Convertible Senior Notes Offering
(RTTNews) - CRISPR Therapeutics AG (CRSP), Wednesday announced the pricing of 0 million of its convertible senior notes due 2031 in a private offering to persons reasonably believed to be qualified institutional buyers.
Announcement as on 11 March 2026
CRISPR Therapeutics Plans 0 Mln Convertible Senior Notes Offering
(RTTNews) - CRISPR Therapeutics AG (CRSP), on Tuesday said it intends to offer 0 million aggregate principal amount of convertible senior notes due 2031 in a private placement.
Announcement as on 10 March 2026
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows
CRISPR Therapeutics AG (NASDAQ: CRSP) stock is up more than 12% after the gene editing pioneer reported its Q4 2025 earnings on Feb. 13. At first glance, that may seem contradictory. The company posted a larger net loss than forecast, and revenue came in a
Announcement as on 19 February 2026
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026?
Key PointsCRISPR has incurred nearly 0 million in losses over the past four quarters.
Announcement as on 19 December 2025
Announcements by Crispr Therapeutics Ag first page | Next page |
CRSP Crispr Therapeutics Ag current price & indicator signals
Recent prices of CRSP Crispr Therapeutics Ag are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 18 Mon May 2026 | 48.56 | 48.07 to 50.08 | 0.31% | 1.27 times |
| 15 Fri May 2026 | 48.41 | 48.25 to 50.45 | -4.04% | 0.86 times |
| 14 Thu May 2026 | 50.45 | 50.23 to 53.49 | -4.36% | 0.74 times |
| 13 Wed May 2026 | 52.75 | 52.36 to 53.81 | -0.13% | 0.66 times |
| 12 Tue May 2026 | 52.82 | 52.02 to 54.30 | -2.2% | 0.37 times |
| 11 Mon May 2026 | 54.01 | 53.84 to 56.16 | -1.5% | 0.94 times |
| 08 Fri May 2026 | 54.83 | 52.55 to 55.85 | 4.6% | 1.24 times |
| 07 Thu May 2026 | 52.42 | 51.71 to 55.47 | -4.85% | 1.09 times |
| 06 Wed May 2026 | 55.09 | 52.65 to 55.40 | 0.02% | 0.85 times |
| 06 Wed May 2026 | 55.08 | 52.65 to 55.40 | 5.11% | 1.81 times |
| 05 Tue May 2026 | 52.40 | 49.38 to 53.94 | -2.2% | 1.44 times |
| 04 Mon May 2026 | 53.58 | 51.77 to 54.41 | 3.78% | 1.22 times |
Videos related to: CRSP announcements Crispr Therapeutics Ag announcements and dividends declared USA
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


